FDA Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
Links shared publicly online about this topic.
- 2,077total visits
FDA Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
View full resource at drugs.com
Tags: Botulism, Spasmodic Torticollis Medication, Botox, FDA
Most Recently Shared on April 30, 2009 at 10:59 pm By:
FDA Alert - Boxed Warning for Botox, Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) http://tinyurl.com/dlllvs
Manufacturers of botulinum toxin products (Botox, Botox Cosmetic, Myobloc) required to strengthen warnings - MPR
empr.com — “The FDA has notified healthcare professionals that it is requiring the manufacturers of licensed botulinum toxin products, including Botox and Botox Cosmetic (botulinum toxin type A, from Allergan) and Myobloc (botulinum toxin type B, from Solstice Neurosciences), to strengthen warnings in product labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spreads beyond the injection site.” View full resource at empr.com
Most Recently Shared on April 30, 2009 at 8:05 pm By:
MPR News: Manufacturers of botulinum toxin products (Botox, Botox Cosmetic, Myobloc) required to streng.. http://tinyurl.com/c674rf
Advertisement
